These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 19560215

  • 1. Acute neuroinflammation in Lewis rats - a model for acute multiple sclerosis relapses.
    Schneider C, Schuetz G, Zollner TM.
    J Neuroimmunol; 2009 Aug 18; 213(1-2):84-90. PubMed ID: 19560215
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis.
    Stanislaus R, Singh AK, Singh I.
    J Neurosci Res; 2001 Oct 15; 66(2):155-62. PubMed ID: 11592110
    [Abstract] [Full Text] [Related]

  • 5. Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
    Moriya M, Nakatsuji Y, Okuno T, Hamasaki T, Sawada M, Sakoda S.
    J Neuroimmunol; 2005 Dec 30; 170(1-2):11-20. PubMed ID: 16146654
    [Abstract] [Full Text] [Related]

  • 6. Possible role of ependymal proliferation in improving experimental allergic encephalomyelitis in Lewis rats.
    Mohamed A, Yunus M, Hamadain E, Benghuzzi H.
    Biomed Sci Instrum; 2006 Dec 30; 42():405-9. PubMed ID: 16817642
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.
    Wiemann B, Van GY, Danilenko DM, Yan Q, Matheson C, Munyakazi L, Ogenstad S, Starnes CO.
    Exp Neurol; 1998 Feb 30; 149(2):455-63. PubMed ID: 9500957
    [Abstract] [Full Text] [Related]

  • 10. RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis.
    DeVry CG, Valdez M, Gao L, Wang J, Kotsch K, Volk HD, Bechmann I, Buelow R, Iyer S.
    J Neuroimmunol; 2004 Jul 30; 152(1-2):33-43. PubMed ID: 15223235
    [Abstract] [Full Text] [Related]

  • 11. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis.
    Karpus WJ, Ransohoff RM.
    J Immunol; 1998 Sep 15; 161(6):2667-71. PubMed ID: 9743321
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis.
    Tham E, Gielen AW, Khademi M, Martin C, Piehl F.
    Scand J Immunol; 2006 Dec 15; 64(6):609-22. PubMed ID: 17083617
    [Abstract] [Full Text] [Related]

  • 13. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM, Alvord EC.
    Prog Clin Biol Res; 1984 Dec 15; 146():61-6. PubMed ID: 6201924
    [No Abstract] [Full Text] [Related]

  • 14. Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1.
    Kang JC, Ahn M, Kim YS, Moon C, Lee Y, Wie MB, Lee YJ, Shin T.
    J Vet Sci; 2001 Aug 15; 2(2):85-9. PubMed ID: 14614276
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
    Jee Y, Yoon WK, Okura Y, Tanuma N, Matsumoto Y.
    J Neuroimmunol; 2002 Jul 15; 128(1-2):49-57. PubMed ID: 12098510
    [Abstract] [Full Text] [Related]

  • 16. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
    Petry KG, Boullerne AI, Pousset F, Brochet B, Caillé JM, Dousset V.
    Pathol Biol (Paris); 2000 Feb 15; 48(1):47-53. PubMed ID: 10729911
    [Abstract] [Full Text] [Related]

  • 17. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
    Mohamed A, Tarhuni H, Dufan T, Benghuzzi H, Tucci M.
    Biomed Sci Instrum; 2004 Feb 15; 40():419-23. PubMed ID: 15133994
    [Abstract] [Full Text] [Related]

  • 18. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V, Taradi SK, Andreis I, Zupancić V, Taradi M.
    Lijec Vjesn; 2001 Feb 15; 123(3-4):81-8. PubMed ID: 11488222
    [Abstract] [Full Text] [Related]

  • 19. Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis.
    Sun D, Newman TA, Perry VH, Weller RO.
    Neuropathol Appl Neurobiol; 2004 Aug 15; 30(4):374-84. PubMed ID: 15305983
    [Abstract] [Full Text] [Related]

  • 20. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep 15; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.